MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
+0.01
(+0.36%)
After-Hours: 20:00
MEI Pharma Price to Book Value: 0.7445 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 0.7445 |
| November 21, 2024 | 0.7526 |
| November 20, 2024 | 0.7499 |
| November 19, 2024 | 0.766 |
| November 18, 2024 | 0.77 |
| November 15, 2024 | 0.782 |
| November 14, 2024 | 0.8061 |
| November 13, 2024 | 0.8115 |
| November 12, 2024 | 0.841 |
| November 11, 2024 | 0.8383 |
| November 08, 2024 | 0.8142 |
| November 07, 2024 | 0.8115 |
| November 06, 2024 | 0.8142 |
| November 05, 2024 | 0.8142 |
| November 04, 2024 | 0.8195 |
| November 01, 2024 | 0.8222 |
| October 31, 2024 | 0.8303 |
| October 30, 2024 | 0.8329 |
| October 29, 2024 | 0.849 |
| October 28, 2024 | 0.8262 |
| October 25, 2024 | 0.7312 |
| October 24, 2024 | 0.7325 |
| October 23, 2024 | 0.7338 |
| October 22, 2024 | 0.7365 |
| October 21, 2024 | 0.7338 |
| Date | Value |
|---|---|
| October 18, 2024 | 0.7419 |
| October 17, 2024 | 0.7365 |
| October 16, 2024 | 0.7419 |
| October 15, 2024 | 0.7258 |
| October 14, 2024 | 0.7151 |
| October 11, 2024 | 0.7231 |
| October 10, 2024 | 0.7231 |
| October 09, 2024 | 0.7178 |
| October 08, 2024 | 0.7258 |
| October 07, 2024 | 0.7419 |
| October 04, 2024 | 0.7526 |
| October 03, 2024 | 0.7365 |
| October 02, 2024 | 0.7365 |
| October 01, 2024 | 0.7499 |
| September 30, 2024 | 0.7633 |
| September 27, 2024 | 0.5852 |
| September 26, 2024 | 0.5852 |
| September 25, 2024 | 0.5771 |
| September 24, 2024 | 0.5953 |
| September 23, 2024 | 0.5912 |
| September 20, 2024 | 0.6013 |
| September 19, 2024 | 0.6336 |
| September 18, 2024 | 0.6134 |
| September 17, 2024 | 0.6054 |
| September 16, 2024 | 0.6154 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.363
Minimum
Jun 24 2024
11.94
Maximum
Nov 30 2021
3.013
Average
1.621
Median
Price to Book Value Benchmarks
| Avid Bioservices Inc | 13.38 |
| Evoke Pharma Inc | 1.467 |
| Revance Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.1758 |
| Price | 2.78 |
| Earnings Yield | -251.4% |
| Market Cap | 18.52M |
| Operating PE Ratio | 0.5042 |
| Normalized PE Ratio | 0.4548 |